These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 28130749

  • 1. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
    Shan LS, Liu X, Kang XY, Wang F, Han XH, Shang YX.
    World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
    [Abstract] [Full Text] [Related]

  • 2. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children].
    Chen L, Liu J, Zhao S, Yang Y, Wu J.
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):172-6. PubMed ID: 24824385
    [Abstract] [Full Text] [Related]

  • 3. Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children.
    Luo Z, Luo J, Liu E, Xu X, Liu Y, Zeng F, Li S, Fu Z.
    Pediatr Pulmonol; 2014 Apr; 49(4):377-80. PubMed ID: 23401275
    [Abstract] [Full Text] [Related]

  • 4. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F, Qu JX, Liu ZJ, Qin XG, Cao B.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [Abstract] [Full Text] [Related]

  • 5. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study.
    Wen J, Su Y, Sun H, Zhang H, Li H.
    Respir Res; 2021 Mar 22; 22(1):89. PubMed ID: 33752670
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.
    Huang X, Li D, Liu F, Zhao D, Zhu Y, Tang H.
    BMC Infect Dis; 2021 Jan 06; 21(1):14. PubMed ID: 33407216
    [Abstract] [Full Text] [Related]

  • 7. Effect of Methylprednisolone Plus Azithromycin on Fractional Exhaled Nitric Oxide and Peripheral Blood Eosinophils in Children with Refractory Mycoplasma Pneumoniae Pneumonia.
    Zhou H, Chen X, Li J.
    J Coll Physicians Surg Pak; 2022 Jan 06; 32(1):33-36. PubMed ID: 34983144
    [Abstract] [Full Text] [Related]

  • 8. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level.
    Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, Kondo E, Teranishi H, Wakabayashi T, Akaike H, Tanaka T, Ogita S, Nakano T, Terada K, Ouchi K.
    J Infect Chemother; 2014 Apr 06; 20(4):270-3. PubMed ID: 24486173
    [Abstract] [Full Text] [Related]

  • 9. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid.
    Lu A, Wang L, Zhang X, Zhang M.
    Pediatr Pulmonol; 2011 Nov 06; 46(11):1093-7. PubMed ID: 21698787
    [Abstract] [Full Text] [Related]

  • 10. Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study.
    Huang L, Huang X, Jiang W, Zhang R, Yan Y, Huang L.
    BMJ Open; 2018 Dec 18; 8(12):e023719. PubMed ID: 30567824
    [Abstract] [Full Text] [Related]

  • 11. [Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels].
    Lan Y, Yang D, Chen Z, Tang L, Xu Y, Cheng Y.
    Zhonghua Er Ke Za Zhi; 2015 Oct 18; 53(10):779-83. PubMed ID: 26758116
    [Abstract] [Full Text] [Related]

  • 12. Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies.
    Ahluwalia J, Wan J, Lee DH, Treat J, Yan AC.
    Pediatr Dermatol; 2014 Oct 18; 31(6):664-9. PubMed ID: 25424206
    [Abstract] [Full Text] [Related]

  • 13. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.
    Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z.
    PLoS One; 2016 Oct 18; 11(5):e0156465. PubMed ID: 27227519
    [Abstract] [Full Text] [Related]

  • 14. [Mycoplasma pneumoniae-associated mucositis: a case report].
    Yin J, Li X, Liu L, Hu J, Li C.
    Zhonghua Er Ke Za Zhi; 2014 May 18; 52(5):399-400. PubMed ID: 24969943
    [No Abstract] [Full Text] [Related]

  • 15. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.
    Fan F, Lv J, Yang Q, Jiang F.
    Clin Respir J; 2023 Jul 18; 17(7):607-617. PubMed ID: 37142438
    [Abstract] [Full Text] [Related]

  • 16. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.
    Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T.
    J Infect; 2008 Sep 18; 57(3):223-8. PubMed ID: 18656264
    [Abstract] [Full Text] [Related]

  • 17. [Early identification of refractory Mycoplasma pneumoniae pneumonia in children].
    Wang Z, Li YC, Chen L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov 18; 17(11):1189-92. PubMed ID: 26575876
    [Abstract] [Full Text] [Related]

  • 18. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.
    Choi YJ, Jeon JH, Oh JW.
    Respir Res; 2019 Aug 23; 20(1):193. PubMed ID: 31443650
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report.
    Luo H, Wang S, Yuan T, Liu J, Yao L, Pan X, Long X, Wu J, Shen F.
    J Med Case Rep; 2018 Mar 15; 12(1):77. PubMed ID: 29540219
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy.
    Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y.
    BMC Infect Dis; 2021 Jan 28; 21(1):126. PubMed ID: 33509121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.